Senseonics (NYSE:SENS) announced that it closed its previously announced public offering and private placement with Abbott.

Sequel Med Tech announced today that it agreed to integrate its twiist automated insulin delivery system with a future Abbott ...

Embecta (Nasdaq:EMBC) today revealed its phased plan to create value and shift priorities toward broader medical applications ...

Embecta now expects revenues between $1.073 billion and $1.09 billion. This would mark a sales dip of between 4.4% and 2.9% ...

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.

Tandem Diabetes Care (Nasdaq:TNDM) filed an SEC Form 8-K to state that it received CE mark for its Mobi insulin delivery ...

Senseonics (NYSE:SENS) announced today that it commenced an underwritten public offering of common stock worth $50 million.

Dexcom (Nasdaq:DXCM) announced today that it promoted Jake Leach to the role of president, in addition to his post as COO.

Abbott today announced results from real-world studies demonstrating benefits with its FreeStyle Libre CGM technology.

BD (NYSE:BDX) filed a lawsuit in a U.S. District Court alleging patent infringement by Baxter (NYSE:BAX) related to infusion ...

Roche announced today that it plans to invest up to $550 million to expand its continuous glucose monitoring (CGM) site in ...

Insulet recorded a 31.3% bottom-line slide on a sales increase of 28.8%. Adjusted to exclude one-time items, earnings per ...